User:Mr. Ibrahem/Alefacept

Alefacept, sold under the brand name Amevive, is a medication previously used to treat moderate to severe plaque psoriasis. There are; however, more effective and better tolerated options. It was given by injection into a vein or muscle.

Common side effects included headache, dizziness, nausea, muscle pain, pain at the site of injection, and infection. Other side effects may include low lymphocytes, allergic reactions, and cancer. Safety in pregnancy is unclear. It is a fusion protein which combines part of an antibody with a protein that blocks the growth of some types of T cells.

Alefacept was approved for medical use in the United States in 2003. It; however, was withdrawn from the market in 2011.